Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers
Cold Spring Harbor Perspectives in Medicine · 2024
DOI: 10.1101/cshperspect.a041536 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cold Spring Harbor Perspectives in Medicine, 2024. Verfasst von Daniel Peled und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa 3525433, Israel. Hauptthemen laut MEDLINE: Citric Acid Cycle, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa 3525433, Israel.
- Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
- Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA EGottlieb@mdanderson.org.
Zitieren
APA
Peled, D., Casey, R., & Gottlieb, E. (2024). Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a041536
Vancouver
Peled D, Casey R, Gottlieb E. Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers. Cold Spring Harbor Perspectives in Medicine. 2024. doi:10.1101/cshperspect.a041536
BibTeX
@article{Peled2024,
author = {Peled, Daniel and Casey, Ruth and Gottlieb, Eyal},
title = {Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers},
journal = {Cold Spring Harbor Perspectives in Medicine},
year = {2024},
doi = {10.1101/cshperspect.a041536}
}
EUVIMED